{"id":54620,"date":"2009-11-25T10:55:03","date_gmt":"2009-11-25T15:55:03","guid":{"rendered":"http:\/\/www.technologytransfertactics.com\/content\/?p=5375"},"modified":"2009-11-25T10:55:03","modified_gmt":"2009-11-25T15:55:03","slug":"new-tool-slashes-time-and-expense-from-medical-device-commercialization-process","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/54620","title":{"rendered":"New tool slashes time and expense from medical device commercialization process"},"content":{"rendered":"<p>A new Software-as-a-Service tool that in less than 20 minutes provides                crucial information needed for determining the FDA classification                and regulatory pathway for medical device technology has just been                released by e-Zassi, and is being offered with an introductory discount                in partnership with 2Market Information Inc., the parent company                of <em>Tech Transfer E-News<\/em>.<\/p>\n<p>Within minutes, the <strong>US FDA Regulatory Calculator<\/strong> provides users with a potential FDA predicate, regulation product                code, and the classification and regulatory pathway associated with                a medical technology. With this new tool, you&#8217;ll save hours in initial                research and eliminate the need for outside experts early in the                process. Understanding the classification and regulatory pathway                of new medical device technologies is critical to early business                planning, market assessment, and understanding of FDA requirements.                Typically, this takes in-house staff or outside consultants many                research hours, can delay product development, and eats up additional                time and money. The new tool puts regulatory pathway information                at your fingertips early in the device development process, minimizing                the potential for miscalculations with due diligence and helping                to guide your commercialization and clinical trial strategy. For                complete details, and to receive a $125 discount (<em>E-News<\/em> readers pay only $375), <a href=\"http:\/\/www.ipmarketingadvisor.com\/content\/fdarc-en\/\">CLICK                HERE<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new Software-as-a-Service tool that in less than 20 minutes provides crucial information needed for determining the FDA classification and regulatory pathway for medical device technology has just been released by e-Zassi, and is being offered with an introductory discount in partnership with 2Market Information Inc., the parent company of Tech Transfer E-News. Within minutes, [&hellip;]<\/p>\n","protected":false},"author":67,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-54620","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/54620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=54620"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/54620\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=54620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=54620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=54620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}